Shang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shang Li has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Ying Jie
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing 100730, China
9 shared publications - Zhiqiang Pan
Beijing Ophthalmology and Visual Science Key Laboratory, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China
3 shared publications - Ao Li
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing 100730, China
2 shared publications Chungang Guo
Department of Ophthalmology, Beijing YouAn Hospital, Capital Medical University, Beijing, China
2 shared publicationsHongshuang Lu
Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing, China
2 shared publications- Lei Tian
Beijing Tongren Hospital, Capital Medical University
2 shared publications
Latest Publications
- 29 October 2026
- Published by Taylor & Francis in Current Eye Research
- p. 1-12
A Prospective Cohort Study of Clinical Outcomes, Tear Cytokines and Proteomic Profiles Following Insular Infraorbital Neurovascular Pedicle Labial Salivary Gland Transplantation for Severe Dry Eye Disease
Dry eye disease (DED) is a multifactorial disease characterized by a loss of tear film homeostasis, in which tear film instability, hyperosmolarity, ocular surface inflammation, and neurosensory ab...
- 29 October 2026
- Published by Taylor & Francis in Current Eye Research
- p. 1-12
A Prospective Cohort Study of Clinical Outcomes, Tear Cytokines and Proteomic Profiles Following Insular Infraorbital Neurovascular Pedicle Labial Salivary Gland Transplantation for Severe Dry Eye Disease
Dry eye disease (DED) is a multifactorial disease characterized by a loss of tear film homeostasis, in which tear film instability, hyperosmolarity, ocular surface inflammation, and neurosensory ab...
- Open Access
- 15 September 2026
- Published by Springer Nature in BMC Ophthalmology
Peripheral pachymetry, eccentricity, and composite tomographic-biomechanical indices for screening forme fruste/suspect keratoconus
- 15 September 2026
- Published by Springer Nature in BMC Ophthalmology
Open AccessPeripheral pachymetry, eccentricity, and composite tomographic-biomechanical indices for screening forme fruste/suspect keratoconus
- Open Access
- 27 April 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (9) , 13906-13917
Efficacy and safety of Mihe keratoprosthesis in Chinese population: a retrospective single-center study
Aim: The aim of this study is to quantify anatomical and functional outcomes of the Mihe keratoprosthesis (KPro) in a Chinese population over a period of 1–3 years and analyze the possible causes of postoperative complications. Materials and methods: Patients who completed both stage 1 and stage 2 Mihe KPro surgery more than or equal to 1 year were included. The interval between stage 1 and stage 2 of the procedure, specifications of the KPro, prognosis, postoperative complications, and any subsequent surgeries were documented. Indications, intraoperative characteristics, postoperative visual acuity, and complications were analyzed. Results: Twenty-eight eyes of 28 patients who underwent Mihe KPro surgery were reviewed with a mean follow-up of 14.4 ± 5.3 months. Chemical burn was shown to be the most common indication for KPro surgery with 13 cases (46.4%). The final postoperative best-corrected visual acuity (BCVA) improved in 22 eyes (78.6%). Postoperative BCVA improved to 0.5 logMAR or better in nine eyes (32.1%) and 1.3 logMAR or better in 14 eyes (50.0%) at 12 months. The retention rate of Mihe KPro was 100% (28 eyes). Complications including anterior proliferative membrane (25.0%), exposure of the KPro stent (7.1%), glaucoma (7.1%), exposure of autologous auricular cartilage (7.1%), retroprosthetic membrane (3.6%), proliferative growth on the surface of the autologous auricular cartilage (3.6%), central retinal artery occlusion (3.6%), and endophthalmitis and retinal detachment (3.6%). Conclusions: Mihe KPro’s wholly domestic design and production mark is a pivotal milestone for Chinese ophthalmology. It offers a new therapeutic option for end-stage corneal blindness, but its long-term efficacy and safety still require validation through larger sample sizes and longer follow-up durations.
- 27 April 2026
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 112 (9) , 13906-13917
Open AccessEfficacy and safety of Mihe keratoprosthesis in Chinese population: a retrospective single-center study
Aim: The aim of this study is to quantify anatomical and functional outcomes of the Mihe keratoprosthesis (KPro) in a Chinese population over a period of 1–3 years and analyze the possible causes of postoperative complications. Materials and methods: Patients who completed both stage 1 and stage 2 Mihe KPro surgery more than or equal to 1 year were included. The interval between stage 1 and stage 2 of the procedure, specifications of the KPro, prognosis, postoperative complications, and any subsequent surgeries were documented. Indications, intraoperative characteristics, postoperative visual acuity, and complications were analyzed. Results: Twenty-eight eyes of 28 patients who underwent Mihe KPro surgery were reviewed with a mean follow-up of 14.4 ± 5.3 months. Chemical burn was shown to be the most common indication for KPro surgery with 13 cases (46.4%). The final postoperative best-corrected visual acuity (BCVA) improved in 22 eyes (78.6%). Postoperative BCVA improved to 0.5 logMAR or better in nine eyes (32.1%) and 1.3 logMAR or better in 14 eyes (50.0%) at 12 months. The retention rate of Mihe KPro was 100% (28 eyes). Complications including anterior proliferative membrane (25.0%), exposure of the KPro stent (7.1%), glaucoma (7.1%), exposure of autologous auricular cartilage (7.1%), retroprosthetic membrane (3.6%), proliferative growth on the surface of the autologous auricular cartilage (3.6%), central retinal artery occlusion (3.6%), and endophthalmitis and retinal detachment (3.6%). Conclusions: Mihe KPro’s wholly domestic design and production mark is a pivotal milestone for Chinese ophthalmology. It offers a new therapeutic option for end-stage corneal blindness, but its long-term efficacy and safety still require validation through larger sample sizes and longer follow-up durations.
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1) , 6682142
Three‐Year Visual Quality Evaluation in Children Using Orthokeratology Lenses: A Retrospective Study With OPD‐Scan III Measurements
Purpose: To evaluate long‐term visual quality outcomes, refractive changes, and safety during orthokeratology lens wear in children with myopia over a 3‐year period. Methods: We conducted a retrospective analysis of 130 myopic children aged 8–18 years who wore corneal refractive therapy (CRT) lenses from February 2021 to November 2024. Participants underwent comprehensive ocular examinations, including assessments of visual acuity, refractive error, axial length, corneal thickness, and visual quality parameters at baseline, 1.5 years, and 3 years. Data were analyzed with repeated measures ANOVA, and post hoc comparisons were conducted using the Bonferroni test. Results: Over the three‐year period, there was a slight increase in myopic refractive error and axial length (spherical equivalent: from −1.36 ± 1.17D to −1.69 ± 1.24D; cylindrical power: from −0.70 ± 0.83D to −1.18 ± 0.99D; axial length: from 24.62 ± 0.83 to 25.08 ± 0.85 mm). Overall ocular visual quality improved significantly, with increases in Strehl ratio and modulation transfer function ( p < 0.001), while root mean square (RMS) of total ocular aberrations decreased ( p < 0.001). After 1.5 years of wear, the corneal high‐order aberration (HOA) RMS, corneal spherical aberration (SA) RMS, corneal coma RMS, and corneal tilt RMS all significantly increased ( p < 0.0167), while corneal HOAs in the 5‐mm optical zone were generally greater than those in the 3‐mm optical zone ( p < 0.05). Total intraocular aberration RMS decreased significantly in both zones ( p < 0.001). No significant changes were observed in corneal endothelial cell density, and no cases of microbial keratitis or other vision‐threatening complications occurred. Conclusion: Long‐term CRT lens wear was associated with improved overall and intraocular visual quality, despite increased corneal HOA, with better optical performance in the 3‐mm zone. The observed axial elongation and refractive changes over 3 years were broadly consistent with previously reported orthokeratology outcomes. CRT lenses also demonstrated a favorable safety profile in this cohort.
- 1 January 2026
- Published by Wiley in Journal of Ophthalmology
- Vol. 2026 (1) , 6682142
Open AccessThree‐Year Visual Quality Evaluation in Children Using Orthokeratology Lenses: A Retrospective Study With OPD‐Scan III Measurements
Purpose: To evaluate long‐term visual quality outcomes, refractive changes, and safety during orthokeratology lens wear in children with myopia over a 3‐year period. Methods: We conducted a retrospective analysis of 130 myopic children aged 8–18 years who wore corneal refractive therapy (CRT) lenses from February 2021 to November 2024. Participants underwent comprehensive ocular examinations, including assessments of visual acuity, refractive error, axial length, corneal thickness, and visual quality parameters at baseline, 1.5 years, and 3 years. Data were analyzed with repeated measures ANOVA, and post hoc comparisons were conducted using the Bonferroni test. Results: Over the three‐year period, there was a slight increase in myopic refractive error and axial length (spherical equivalent: from −1.36 ± 1.17D to −1.69 ± 1.24D; cylindrical power: from −0.70 ± 0.83D to −1.18 ± 0.99D; axial length: from 24.62 ± 0.83 to 25.08 ± 0.85 mm). Overall ocular visual quality improved significantly, with increases in Strehl ratio and modulation transfer function ( p < 0.001), while root mean square (RMS) of total ocular aberrations decreased ( p < 0.001). After 1.5 years of wear, the corneal high‐order aberration (HOA) RMS, corneal spherical aberration (SA) RMS, corneal coma RMS, and corneal tilt RMS all significantly increased ( p < 0.0167), while corneal HOAs in the 5‐mm optical zone were generally greater than those in the 3‐mm optical zone ( p < 0.05). Total intraocular aberration RMS decreased significantly in both zones ( p < 0.001). No significant changes were observed in corneal endothelial cell density, and no cases of microbial keratitis or other vision‐threatening complications occurred. Conclusion: Long‐term CRT lens wear was associated with improved overall and intraocular visual quality, despite increased corneal HOA, with better optical performance in the 3‐mm zone. The observed axial elongation and refractive changes over 3 years were broadly consistent with previously reported orthokeratology outcomes. CRT lenses also demonstrated a favorable safety profile in this cohort.
- Open Access
- 1 January 2023
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 16
Leucocytoclastic Vasculitis Presenting as Bilateral Ulcerative Keratitis: A Case Report
Introduction: Small artery disease caused by neutrophils and immune-mediated is known as leucocytoclastic vasculitis (LCV). Clinically, it manifests as palpable, asymptomatic purpuric papules on the limbs. Ocular manifestation is rare. Here, we describe a case of peripheral ulcerative keratitis (PUK) associated with LCV. Case presentation: A 59-year-old man was referred to the hospital with blurred vision due to corneal perforation in his left eye. He complained of itchy nodules on his hands and lower legs for 15 years and the skin biopsy of the back of his hand revealed LCV 6 years ago, which suggested erythema elevatum diutinum. The patient was under treatment with anti-inflammatory and immunosuppressive drugs and physical features of LCV seen in him included erythema on his hands and legs. After receiving conjunctival flap covering surgery, the corneal perforation was resolved. Conjunctival flaps covered cornea that limited his vision to hand motion. Six months later, he was referred to our clinic again because of pain, redness, photophobia, and tearing in the right eye, presenting with PUK. Necrotic tissue was removed during surgery, which also included a conjunctival flap covering procedure. Following surgery, the symptoms were reduced, and the postoperative eye condition remained stable. Conclusion: To our knowledge, it is the first case of PUK secondary to LCV which was diagnosed 6 years ago. This case demonstrates that PUK associated with LCV can be successfully treated by surgical interventions.
- 1 January 2023
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 16
Open AccessLeucocytoclastic Vasculitis Presenting as Bilateral Ulcerative Keratitis: A Case Report
Introduction: Small artery disease caused by neutrophils and immune-mediated is known as leucocytoclastic vasculitis (LCV). Clinically, it manifests as palpable, asymptomatic purpuric papules on the limbs. Ocular manifestation is rare. Here, we describe a case of peripheral ulcerative keratitis (PUK) associated with LCV. Case presentation: A 59-year-old man was referred to the hospital with blurred vision due to corneal perforation in his left eye. He complained of itchy nodules on his hands and lower legs for 15 years and the skin biopsy of the back of his hand revealed LCV 6 years ago, which suggested erythema elevatum diutinum. The patient was under treatment with anti-inflammatory and immunosuppressive drugs and physical features of LCV seen in him included erythema on his hands and legs. After receiving conjunctival flap covering surgery, the corneal perforation was resolved. Conjunctival flaps covered cornea that limited his vision to hand motion. Six months later, he was referred to our clinic again because of pain, redness, photophobia, and tearing in the right eye, presenting with PUK. Necrotic tissue was removed during surgery, which also included a conjunctival flap covering procedure. Following surgery, the symptoms were reduced, and the postoperative eye condition remained stable. Conclusion: To our knowledge, it is the first case of PUK secondary to LCV which was diagnosed 6 years ago. This case demonstrates that PUK associated with LCV can be successfully treated by surgical interventions.
- Open Access
- 16 September 2019
- Published by Wiley in Journal of Ophthalmology
- Vol. 2019, 1-10
Intense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis
Purpose. To evaluate the intense pulsed light (IPL) therapy with optimal pulse technology (OPT, M22™, Lumenis, USA) as an adjunct therapy for the prevention of recurrences in moderate to severe blepharokeratoconjunctivitis (BKC).Methods. This open-label nonrandomized clinical trial evaluated 33 patients diagnosed with BKC. Twenty-one patients received four bilateral OPT therapy sessions with Meibomian gland expression (MGX) (treatment group), and 11 patients received MGX alone (controls). This trial was initiated after a four-week pharmacotherapy for BKC in both groups and was scheduled at four-week intervals. Efficacy outcome measures included meibum quality, Meibomian gland (MG) secretion function, eyelid margin signs, corneal fluorescein staining (CFS) score, noninvasive keratography breakup time (NIKBUT), ocular surface disease index (OSDI) score, Schirmer I test (SIT), classification of tear film lipid layer (TFLL), and Meibomian gland dropout (MGDR). Safety outcome measures included visual acuity, intraocular pressure, eye structure damage, and facial skin appearance at each visit.Results. Quality of meibum, MG expressibility, eyelid margin signs, and OSDI score showed a statistically significant greater improvement in the treatment group after one to three treatment sessions, compared to controls (). While these improved in both groups in comparison to baseline, the NIKBUT and upper and lower eyelid MGDRs significantly improved only in the treatment group (). No adverse events occurred in both groups. No BKC recurrences were noted in the treatment group.Conclusions. IPL is a safe and effective adjuvant treatment for BKC and possibly more effective in reducing eyelid margin inflammation and prevents recurrences than MGX alone. This trial is registered withChiCTR-ONN-17013864.- 16 September 2019
- Published by Wiley in Journal of Ophthalmology
- Vol. 2019, 1-10
Open AccessIntense Pulsed Light Therapy with Optimal Pulse Technology as an Adjunct Therapy for Moderate to Severe Blepharitis-Associated Keratoconjunctivitis
Purpose. To evaluate the intense pulsed light (IPL) therapy with optimal pulse technology (OPT, M22™, Lumenis, USA) as an adjunct therapy for the prevention of recurrences in moderate to severe blepharokeratoconjunctivitis (BKC).Methods. This open-label nonrandomized clinical trial evaluated 33 patients diagnosed with BKC. Twenty-one patients received four bilateral OPT therapy sessions with Meibomian gland expression (MGX) (treatment group), and 11 patients received MGX alone (controls). This trial was initiated after a four-week pharmacotherapy for BKC in both groups and was scheduled at four-week intervals. Efficacy outcome measures included meibum quality, Meibomian gland (MG) secretion function, eyelid margin signs, corneal fluorescein staining (CFS) score, noninvasive keratography breakup time (NIKBUT), ocular surface disease index (OSDI) score, Schirmer I test (SIT), classification of tear film lipid layer (TFLL), and Meibomian gland dropout (MGDR). Safety outcome measures included visual acuity, intraocular pressure, eye structure damage, and facial skin appearance at each visit.Results. Quality of meibum, MG expressibility, eyelid margin signs, and OSDI score showed a statistically significant greater improvement in the treatment group after one to three treatment sessions, compared to controls (). While these improved in both groups in comparison to baseline, the NIKBUT and upper and lower eyelid MGDRs significantly improved only in the treatment group (). No adverse events occurred in both groups. No BKC recurrences were noted in the treatment group.Conclusions. IPL is a safe and effective adjuvant treatment for BKC and possibly more effective in reducing eyelid margin inflammation and prevents recurrences than MGX alone. This trial is registered withChiCTR-ONN-17013864. - Open Access
- 22 May 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-10
The Effects of Anti-LAP Monoclonal Antibody Down-regulation of CD4+LAP+ T Cells on Allogeneic Corneal Transplantation in Mice
CD4+latency-associated peptide (LAP)+ T cells are a newly discovered T cell subset with suppressive function on immune responses. In this study, we investigate the role of CD4+LAP+ T cells on mice corneal allograft survival by down-regulating their expression using anti-LAP mAb. We show that a blockage of LAP leads to a decrease in the percentage of T cells expressing CD4+Foxp3+, CD4+GARP+, CD4+LAP+ and CD4+IL-10+ in the lymph nodes and spleens of mice undergoing orthotopic penetrating transplantation of corneal allograft, without affecting corneal graft survival. In addition, higher percentages of CD4+IFN-γ+ and CD4+IL-17A+ T cells in the lymph nodes and spleens, as well as TNF, IFN-γ, IL-17A and IL-6 levels in the aqueous humor, significantly increase in mice with rejected corneal grafts. The expression of TGF-β1 decreases in corneal grafts during corneal rejection period. It is therefore possible that anti-LAP mAb can down-regulate the regulatory T cell subsets with its immunosuppressive effects. The rejection of corneal grafts seems to mainly be associated with the up-regulation of Th1 and Th17 cell subsets in peripheral lymph nodes.
- 22 May 2018
- Published by Springer Nature in Scientific Reports
- Vol. 8 (1) , 1-10
Open AccessThe Effects of Anti-LAP Monoclonal Antibody Down-regulation of CD4+LAP+ T Cells on Allogeneic Corneal Transplantation in Mice
CD4+latency-associated peptide (LAP)+ T cells are a newly discovered T cell subset with suppressive function on immune responses. In this study, we investigate the role of CD4+LAP+ T cells on mice corneal allograft survival by down-regulating their expression using anti-LAP mAb. We show that a blockage of LAP leads to a decrease in the percentage of T cells expressing CD4+Foxp3+, CD4+GARP+, CD4+LAP+ and CD4+IL-10+ in the lymph nodes and spleens of mice undergoing orthotopic penetrating transplantation of corneal allograft, without affecting corneal graft survival. In addition, higher percentages of CD4+IFN-γ+ and CD4+IL-17A+ T cells in the lymph nodes and spleens, as well as TNF, IFN-γ, IL-17A and IL-6 levels in the aqueous humor, significantly increase in mice with rejected corneal grafts. The expression of TGF-β1 decreases in corneal grafts during corneal rejection period. It is therefore possible that anti-LAP mAb can down-regulate the regulatory T cell subsets with its immunosuppressive effects. The rejection of corneal grafts seems to mainly be associated with the up-regulation of Th1 and Th17 cell subsets in peripheral lymph nodes.
- Open Access
- 8 February 2018
- Published by Wiley in Journal of Ophthalmology
- Vol. 2018, 1-10
The Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation
Purpose. CD4+LAP+ T cells are newly discovered regulatory T cells (Tregs). The aim of this study is to investigate the balance of Th1/Th2 and LAP+Tregs/Th17 in mice after allogeneic corneal transplantation. Methods. A total of 65 mice received orthotopic penetrating transplantation. According to the survival scores of the grafts, the mice were divided into the rejection group and the survival group 3 weeks after transplantation. Th1, Th2, Th17, and regulatory T cells in the ipsilateral drainage lymph nodes and spleens were measured with flow cytometry. The related cytokines in aqueous humor were also analyzed. Results. The frequencies of Foxp3+Tregs, GARP+Tregs, and LAP+Tregs in the survival group were significantly higher than those in the rejection group. And the expression trend of CD4+LAP+ T cells and CD4+GARP+ T cells was consistent. The level of IFN-γ, TNF, IL-6, and IL-17A markedly increased in aqueous humor during corneal allograft rejection. The ratio of Th1/Th2 and Th17/LAP+Tregs significantly increased in the rejection group at the 3rd week after corneal transplantation. Conclusion. LAP+Tregs might be regarded as substitute for Foxp3+Tregs. The balance of Th1/Th2 and LAP+Tregs/Th17 is crucial for corneal allograft survival.
- 8 February 2018
- Published by Wiley in Journal of Ophthalmology
- Vol. 2018, 1-10
Open AccessThe Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation
Purpose. CD4+LAP+ T cells are newly discovered regulatory T cells (Tregs). The aim of this study is to investigate the balance of Th1/Th2 and LAP+Tregs/Th17 in mice after allogeneic corneal transplantation. Methods. A total of 65 mice received orthotopic penetrating transplantation. According to the survival scores of the grafts, the mice were divided into the rejection group and the survival group 3 weeks after transplantation. Th1, Th2, Th17, and regulatory T cells in the ipsilateral drainage lymph nodes and spleens were measured with flow cytometry. The related cytokines in aqueous humor were also analyzed. Results. The frequencies of Foxp3+Tregs, GARP+Tregs, and LAP+Tregs in the survival group were significantly higher than those in the rejection group. And the expression trend of CD4+LAP+ T cells and CD4+GARP+ T cells was consistent. The level of IFN-γ, TNF, IL-6, and IL-17A markedly increased in aqueous humor during corneal allograft rejection. The ratio of Th1/Th2 and Th17/LAP+Tregs significantly increased in the rejection group at the 3rd week after corneal transplantation. Conclusion. LAP+Tregs might be regarded as substitute for Foxp3+Tregs. The balance of Th1/Th2 and LAP+Tregs/Th17 is crucial for corneal allograft survival.